Markus Pirklbauer

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

<scp>FGF</scp>23 is associated with disease severity and prognosis in chronic heart failure

Gerhard Poelzl, Christian Trenkler, Johannes Kliebhan et al. · European Journal of Clinical Investigation · 2014 · 60 citations

Medicine, Cardiology, Endocrinology +13

Chronic kidney disease is more prevalent among women but more men than women are under nephrological care

Michał Lewandowski, Simon Krenn, Amelie Kurnikowski et al. · Wiener klinische Wochenschrift · 2022 · 59 citations · Full text

Medicine, Nephrology, Dialysis +14

Unraveling reno-protective effects of SGLT2 inhibition in human proximal tubular cells

Markus Pirklbauer, Ramona Schupart, Lisa Fuchs et al. · American Journal of Physiology-Renal Physiology · 2018 · 53 citations

Life Sciences, Molecular Biology, Nephrology +16

Renin–Angiotensin–Aldosterone System: From History to Practice of a Secular Topic

Sara H. Ksiazek, Lilio Hu, Sebastiano Andò et al. · International Journal of Molecular Sciences · 2024 · 43 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +15